Boston Scientific initiates trial to evaluate industry's first Modular CRM System
On December 02, 2021, Boston Scientific Corporation started the MODULAR ATP clinical trial to examine the safety, performance, and effectiveness of the mCRM™ Modular Therapy System. The system comprises of two cardiac rhythm management (CRM) devices planned to collaborate to coordinate therapy: the EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System and the EMPOWER™ Modular Pacing System (MPS), which is intended to be the first leadless pacemaker capable of providing both bradycardias pacing support and anti-tachycardia pacing (ATP).
Kenneth...
